AR036871A1 - Procedimiento para la sintesis industrial de (3as)-5,5 dioxo-2,3,3a,4-tetrahidro-1h-pirrolo[2,1-c][1,2,4]benzotiadiazina - Google Patents

Procedimiento para la sintesis industrial de (3as)-5,5 dioxo-2,3,3a,4-tetrahidro-1h-pirrolo[2,1-c][1,2,4]benzotiadiazina

Info

Publication number
AR036871A1
AR036871A1 ARP020101386A ARP020101386A AR036871A1 AR 036871 A1 AR036871 A1 AR 036871A1 AR P020101386 A ARP020101386 A AR P020101386A AR P020101386 A ARP020101386 A AR P020101386A AR 036871 A1 AR036871 A1 AR 036871A1
Authority
AR
Argentina
Prior art keywords
formula
dioxo
compound
industrial synthesis
benzotiadiazine
Prior art date
Application number
ARP020101386A
Other languages
English (en)
Spanish (es)
Inventor
Elsa Foucher
Gilles Thominot
Jean-Pierre Lecouve
James Andrew Ramsden
Christopher James Cobley
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of AR036871A1 publication Critical patent/AR036871A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ARP020101386A 2001-04-18 2002-04-17 Procedimiento para la sintesis industrial de (3as)-5,5 dioxo-2,3,3a,4-tetrahidro-1h-pirrolo[2,1-c][1,2,4]benzotiadiazina AR036871A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0105226A FR2823753B1 (fr) 2001-04-18 2001-04-18 Nouveau procede de synthese de la (3as)-5,5-dioxo-2,3,3a, 4-tetrahydro-1h-pyrrolo [2,1-c] [1,2,4] benzothiadiazine

Publications (1)

Publication Number Publication Date
AR036871A1 true AR036871A1 (es) 2004-10-13

Family

ID=8862416

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020101386A AR036871A1 (es) 2001-04-18 2002-04-17 Procedimiento para la sintesis industrial de (3as)-5,5 dioxo-2,3,3a,4-tetrahidro-1h-pirrolo[2,1-c][1,2,4]benzotiadiazina

Country Status (23)

Country Link
US (1) US6518422B2 (enExample)
EP (1) EP1251132B1 (enExample)
JP (1) JP4011956B2 (enExample)
KR (1) KR100468066B1 (enExample)
CN (1) CN1169811C (enExample)
AR (1) AR036871A1 (enExample)
AT (1) ATE269339T1 (enExample)
AU (1) AU782080B2 (enExample)
BR (1) BR0201307A (enExample)
CA (1) CA2382405C (enExample)
DE (1) DE60200627T2 (enExample)
DK (1) DK1251132T3 (enExample)
EA (1) EA004927B1 (enExample)
ES (1) ES2223031T3 (enExample)
FR (1) FR2823753B1 (enExample)
HU (1) HUP0201256A3 (enExample)
MX (1) MXPA02003639A (enExample)
NO (1) NO20021768L (enExample)
NZ (1) NZ518422A (enExample)
PL (1) PL353512A1 (enExample)
PT (1) PT1251132E (enExample)
SI (1) SI1251132T1 (enExample)
ZA (1) ZA200203085B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2856065B1 (fr) * 2003-06-13 2005-08-19 Servier Lab Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US20060014887A1 (en) * 2004-07-19 2006-01-19 3M Innovative Properties Company Method of hydrolyzing a dispersion of ionic fluoropolymer
FR2879201B1 (fr) * 2004-12-10 2007-02-16 Servier Lab Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DK2230094T3 (en) 2009-03-20 2014-03-03 Kremstal Tuerenwerk Gmbh Process for coating of panels

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3294791A (en) * 1966-03-14 1966-12-27 American Home Prod Tetrahydro-2, 5-methano-1, 2, 5-benzothiadiazepine 1, 1-dioxide
US3471483A (en) * 1967-11-09 1969-10-07 American Home Prod 1 - substituted - 2,3,3a - 4 - tetrahydro - 1h-pyrrolo(2,1 - c)(1,2,4)benzothiadiazine,5,5-dioxide
JPH06192272A (ja) * 1992-12-24 1994-07-12 Japan Tobacco Inc 新規なトリアゾロベンゾチアジアジン及びトリアゾロベンゾチアジアゼピン誘導体
FR2722502B1 (fr) * 1994-07-12 1996-08-23 Adir Nouveau derive de benzothiadiazine, son procede depreparation et les compositions pharmaceutiques qui le contiennent
FR2812291B1 (fr) * 2000-07-28 2002-12-13 Adir Nouveaux derives de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
HUP0201256A2 (hu) 2002-12-28
PT1251132E (pt) 2004-09-30
US20020161222A1 (en) 2002-10-31
FR2823753A1 (fr) 2002-10-25
AU3440502A (en) 2002-10-24
FR2823753B1 (fr) 2004-07-16
JP4011956B2 (ja) 2007-11-21
ZA200203085B (en) 2002-11-25
SI1251132T1 (en) 2004-10-31
MXPA02003639A (es) 2004-11-12
NZ518422A (en) 2002-12-20
JP2003012674A (ja) 2003-01-15
AU782080B2 (en) 2005-06-30
PL353512A1 (en) 2002-10-21
CA2382405C (fr) 2007-03-06
CA2382405A1 (fr) 2002-10-18
EA200200378A2 (ru) 2002-10-31
KR100468066B1 (ko) 2005-01-24
KR20020081148A (ko) 2002-10-26
NO20021768L (no) 2002-10-21
DE60200627T2 (de) 2005-07-14
DE60200627D1 (de) 2004-07-22
HU0201256D0 (enExample) 2002-06-29
ATE269339T1 (de) 2004-07-15
NO20021768D0 (no) 2002-04-15
CN1169811C (zh) 2004-10-06
EA200200378A3 (ru) 2002-12-26
BR0201307A (pt) 2003-06-10
DK1251132T3 (da) 2004-10-25
EP1251132B1 (fr) 2004-06-16
EA004927B1 (ru) 2004-10-28
HK1049668A1 (en) 2003-05-23
CN1381455A (zh) 2002-11-27
HUP0201256A3 (en) 2004-11-29
US6518422B2 (en) 2003-02-11
EP1251132A1 (fr) 2002-10-23
ES2223031T3 (es) 2005-02-16

Similar Documents

Publication Publication Date Title
PE20020532A1 (es) Derivados de naftaleno como agonistas del receptor canabinoide
ES2959967T3 (es) Procedimiento de preparación deN-(5-(4-(4-formil-3-fenil-1h-pirazol-1-il)pirimidin-2-ilamino)-4-metoxi-2-morfolinofenil)acrilamida
NO20075165L (no) Polysyklisk karbamoylpyridonderivat som har integrase inhibitorisk aktivitet.
ECSP034460A (es) Nuevos compuestos heterociclicos, su preparacion y su utilizacion como medicamentos, en especial como antibacterianos
BG106440A (en) Nitrogen-heterocyclic derivatives as nos inhibitors
CA2470423A1 (en) Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol
UY27705A1 (es) Compuestos quimicos.
ZA200409379B (en) Cationically substituted diphenyl azetidinones, method for their production, medicaments containing said compounds and use thereof
AR060010A1 (es) Piridopirazinas y su uso como moduladores de quinasas
ES3040751T3 (en) Manufacture of compounds and compositions for inhibiting the activity of shp2
NO20052781L (no) Forbindelser og prosesser
AU637099B2 (en) 2,5-Diazabicyclo-(2.2.1) heptane derivatives
AR044944A1 (es) Procedimiento par la sintesis de perindopril y sales farmaceuticamente aceptables del mismo
AR044943A1 (es) Procedimiento para la sintesis de perindopril y sales farmaceuticamente aceptables del mismo
AR047312A1 (es) Procedimiento para la sintesis de perindopril y de sus sales farmaceuticamente aceptables
NZ518422A (en) Process for the synthesis of (3aS)-5,5-dioxo-2,3,3a,4-tetrahydro-1H-pyrrolo[2,1-c][1,2,4]benzothiadiazine
GEP20074256B (en) Novel benzothiadiazine, process for their preparation and pharmaceutical compositions containing
MXNL04000051A (es) Proceso para la produccion de un inmunosupresor.
Zhang et al. Preparation of hexaaza and heptaaza macrocycles functionalized with a single aminoalkyl pendant arm
TW200504057A (en) Benzothiophene derivative
ES2077092T3 (es) Procedimiento para la obtencion de pentano-1,5-diaminas 2,2-disubstituidas.
BR9915684A (pt) Semicloridrato de ácido 8-cian-1-ciclopropil-7-(1s,6s-2,8-diazabiciclo-[4.3.0]-non an-8-il)-6-flúor-1,4-dihidro-4-oxo-3-quinolinocarboxìli co
PT1250335E (pt) Processo e intermediarios para a preparacao de imidazopiridinas
ES8607942A1 (es) Procedimiento para la obtencion de derivados de 3-(ureidociclohexilamino)-propan-1, 2-diol
Kishore et al. Synthesis of disubstituted-and deoxydisubstituted-derivatives of α-D-xylofuranose as anticancer agents

Legal Events

Date Code Title Description
FA Abandonment or withdrawal